Allergies & Asthma

Children under 4 years of age with peanut allergies had significantly higher desensitization and remission rates with oral immunotherapy versus placebo, and younger age appeared to predict better outcomes, the randomized IMPACT study showed. Among 146 children ages 1 to 3 years, 71% of those assigned to peanut flour oral immunotherapy became desensitized to a
0 Comments
Traffic-related air pollution was responsible for nearly 2 million new asthma cases in children across the globe in 2019, according to a new study. Of the 1.85 million new pediatric asthma cases that were attributed to nitrogen dioxide (NO2), two-thirds occurred in urban areas, reported Susan Anenberg, PhD, of George Washington University in Washington, D.C.,
0 Comments
Traveling can bring excitement, anxiety, and stress, whether you’re driving a short distance for the day or flying across the country for an extended business trip or vacation. Add food allergies to the mix and traveling can be overwhelming. Researching dining and flight options, communicating your allergies with others, remembering to pack important allergy-friendly items,
0 Comments
When you hear “environmental allergies,” trees, grasses, and weeds might be the first allergens that come to mind. Just when you breathe a sigh of relief from waning outdoor allergens, prepare for sneaky indoor environmental allergens. Mold and dust mites trigger allergies throughout the year. But, as winter rolls around and you begin spending more
0 Comments
The FDA approved the only biologic for severe asthma without any phenotype or biomarker limitations, manufacturers AstraZeneca and Amgen announced Friday. The first-in-class biologic tezepelumab-ekko (Tezspire) is indicated as an add-on maintenance treatment for patients ages 12 and older with severe asthma. It is not intended for acute bronchospasm or status asthmaticus. As a first-in-class
0 Comments
Interventions to de-escalate use of inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD) are necessary and beneficial, researchers said during the federal posters session at the American Society of Health-System Pharmacists (ASHP) Midyear virtual meeting. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines recommend long-acting beta2-agonists (LABA) and long-acting muscarinic
0 Comments
Immune-mediated diseases collectively were associated with an increased risk of cancer, with the risks not always isolated to the involved organ, a large cohort study demonstrated. Overall, 48 common autoimmune and other immune-mediated conditions were linked with a modest total cancer risk (HR 1.08, 95% CI 1.04-1.12), reported Mingyang Song, MD, ScD, of Harvard T.H.
0 Comments
NEW ORLEANS — Everyone who received their second dose of the Moderna or Pfizer mRNA vaccine against COVID-19 at military facilities after experiencing allergic reactions to the first did just fine without any pretreatment, a physician reported here. These individuals were observed closely, of course, and some underwent allergy testing beforehand to ascertain whether they
0 Comments
NEW ORLEANS — Although still technically an orphan disease, hereditary angioedema (HAE) remains a popular focus for drug developers despite a half-dozen products already approved in the U.S. That was on full display at the American College of Allergy, Asthma and Immunology’s annual meeting here, with phase II studies on two investigational agents featured in
0 Comments
NEW ORLEANS — Although 2017 government-endorsed guidelines called for introducing peanuts in infancy in order to minimize risk of future allergy, few parents are getting that message from their pediatricians, survey results indicate. Among 3,062 parents of young children participating in the survey earlier this year, only 58% recalled any discussion with their child’s pediatrician
0 Comments
Two monoclonal antibodies directed toward different interleukin (IL) targets produced wildly different results in randomized phase II trials involving asthma. On the plus side, an IL-33 inhibitor called itepekimab appeared to help patients keep their asthma under control better than placebo, reported Michael Wechsler, MD, of National Jewish Health in Denver, and colleagues. While on
0 Comments
If you suffer from allergies, you likely feel the everyday impacts allergies can cause. We have good news — there is a safe, cost-effective, and convenient option available that might help you enjoy everyday activities and live your ideal lifestyle without worrying about allergies slowing you down. Sublingual immunotherapy (SLIT), commonly known as allergy drops,
0 Comments